Emerging Enterprise Program
The biomedical industry in California, which includes pharmaceutical, biotech, medical device, and diagnostics companies, is shaped by a variety of distinctive forces. Among these, access to capital, an inconsistent and unclear regulatory approval process, high costs of research, great scientific and financial risk, and a range of political issues. The lifeblood of the biomedical industry in California is the small, innovator companies inventing and developing the next generation of therapies for unmet medical needs. CHI firmly believes that it is essential to provide access to critical, timely information, support and programming to meet the needs of emerging enterprise companies’ senior management. Read below to find out more about what CHI offers to companies with under $25 million in revenue and fewer than 100 employees.
- Advocacy and outreach engagement – Policies in Washington and Sacramento have a direct effect on your ability to operate your business successfully in California, from tax and IP issues to capital formation, regulatory and employment issues. Receive communications on particular legislative and policy efforts and activities to ensure your perspective and voice are heard in Washington and Sacramento. Once you join, CHI will keep you well informed and equipped to directly impact advocacy and outreach efforts with other leaders like yourself.
- Events and Webinars – CHI convenes Emerging Enterprise Program executives for in-person meetings and webinars targeted to the interests and concerns of development-stage biomedical companies in California:
- Biomedical Research & Business Roundtable Series: CHI regularly convenes biomedical industry leaders and investors for timely and informative dialogue with policy makers on key issues for advancing biomedical research, development and investment.
- Emerging company communications – CHI knows that emerging enterprises have limited staff and resources. CHI sends regular targeted e-mails and action alerts to most effectively inform and engage program participants on new, high-priority legislative activities at the state and federal level. The activities include group letter-signing campaigns, opportunities for in-person meetings with state and federal legislators and other policymakers, facility tours, promotion of your company to legislator offices, and other activities.
- Leadership development – Once you join CHI, you gain access to senior executives from the biomedical industry in California. The program serves to engage active and committed members and provide leadership development opportunities within the association.
For more information or to participate in CHI’s Emerging Enterprise Program, please contact Molly Ingraham, Vice President-Business Development (Ingraham@chi.org or 858-456-8884).